1. Home
  2. VLRS vs BCAX Comparison

VLRS vs BCAX Comparison

Compare VLRS & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLRS
  • BCAX
  • Stock Information
  • Founded
  • VLRS 2005
  • BCAX 2018
  • Country
  • VLRS Mexico
  • BCAX United States
  • Employees
  • VLRS N/A
  • BCAX N/A
  • Industry
  • VLRS Air Freight/Delivery Services
  • BCAX
  • Sector
  • VLRS Consumer Discretionary
  • BCAX
  • Exchange
  • VLRS Nasdaq
  • BCAX NYSE
  • Market Cap
  • VLRS 636.8M
  • BCAX 670.9M
  • IPO Year
  • VLRS N/A
  • BCAX 2024
  • Fundamental
  • Price
  • VLRS $5.24
  • BCAX $13.26
  • Analyst Decision
  • VLRS Strong Buy
  • BCAX Strong Buy
  • Analyst Count
  • VLRS 7
  • BCAX 6
  • Target Price
  • VLRS $13.00
  • BCAX $34.20
  • AVG Volume (30 Days)
  • VLRS 965.9K
  • BCAX 630.9K
  • Earning Date
  • VLRS 04-22-2025
  • BCAX 03-27-2025
  • Dividend Yield
  • VLRS N/A
  • BCAX N/A
  • EPS Growth
  • VLRS 1492.22
  • BCAX N/A
  • EPS
  • VLRS 0.11
  • BCAX N/A
  • Revenue
  • VLRS $3,142,000,000.00
  • BCAX N/A
  • Revenue This Year
  • VLRS $5.25
  • BCAX N/A
  • Revenue Next Year
  • VLRS $19.50
  • BCAX N/A
  • P/E Ratio
  • VLRS $4.83
  • BCAX N/A
  • Revenue Growth
  • VLRS N/A
  • BCAX N/A
  • 52 Week Low
  • VLRS $5.07
  • BCAX $11.10
  • 52 Week High
  • VLRS $9.57
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • VLRS 29.64
  • BCAX N/A
  • Support Level
  • VLRS $5.07
  • BCAX N/A
  • Resistance Level
  • VLRS $5.72
  • BCAX N/A
  • Average True Range (ATR)
  • VLRS 0.19
  • BCAX 0.00
  • MACD
  • VLRS 0.04
  • BCAX 0.00
  • Stochastic Oscillator
  • VLRS 25.00
  • BCAX 0.00

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central and South America. It currently operates up to 500 average daily flight segments on routes that connect 44 cities in Mexico as well as 22 cities in the United States, four in Central America and two in South America. It uses promotional fares to stimulate demand and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires at the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger revenues and cargo services.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: